One of the biggest quests in biology is understanding how every cell in an animal's body carries an identical genome yet ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

As people grow older, their immune systems do not simply slow down, they often become locked into a simmering, ...

Type 1 diabetes is a disease where the immune system destroys insulin-producing beta cells in pancreatic islets. About 2 million Americans have Type 1 diabetes. The islets of Langerhans are named for ...

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%. The data ...

What keeps our cells the right size? Scientists have long puzzled over this fundamental question, since cells that are too ...

Nearly two million Americans are affected by type 1 diabetes. Diabetes occurs when the body cannot produce enough insulin to breakdown sugar or glucose. As a result, patients have high blood pressure ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach requires chronic suppression of the immune system to prevent rejection of donor cells. A Vertex Pharmaceuticals ...

Multipotent dental stem cells can give rise to various cell types and show potential for treating injuries, diabetes, and ...